Zyla Life Sciences Long-Term Debt, Maturity, Year Five
Zyla Life Sciences had Long-Term Debt, Maturity, Year Five of $69.34 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2020-05-14
- 2020-03-31: Long-Term Debt, Maturity, Year Five $69.34M.
- 2019-12-31: Long-Term Debt, Maturity, Year Five $69.34M.
- 2019-09-30: Long-Term Debt, Maturity, Year Five $9.85M.
- 2019-06-30: Long-Term Debt, Maturity, Year Five $9.86M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2020-03-31 | $69.34M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $69.34M 10-K · filed 2020-03-26 |
| 2019-09-30 | $9.85M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $9.86M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $9.90M 10-Q · filed 2019-05-17 |
| 2017-12-31 | $8.56M 10-K · filed 2018-03-16 |
| 2015-12-31 | $61.00M 10-K · filed 2016-03-11 |